Unknown

Dataset Information

0

Probing the limits of Q-tag bioconjugation of antibodies.


ABSTRACT: Site-selective labelling of antibodies (Abs) can circumvent problems from heterogeneity of conventional conjugation. Here, we evaluate the industrially-applied chemoenzymatic 'Q-tag' strategy based on transglutaminase-mediated (TGase) amide-bond formation in the generation of 89Zr-radiolabelled antibody conjugates. We show that, despite previously suggested high regioselectivity of TGases, in the anti-Her2 Ab Herceptin™ more precise native MS indicates only 70-80% functionalization at the target site (Q298H), in competition with modification at other sites, such as Q3H critically close to the CDR1 region.

SUBMITTER: Marculescu C 

PROVIDER: S-EPMC6788405 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications


Site-selective labelling of antibodies (Abs) can circumvent problems from heterogeneity of conventional conjugation. Here, we evaluate the industrially-applied chemoenzymatic 'Q-tag' strategy based on transglutaminase-mediated (TGase) amide-bond formation in the generation of 89Zr-radiolabelled antibody conjugates. We show that, despite previously suggested high regioselectivity of TGases, in the anti-Her2 Ab Herceptin™ more precise native MS indicates only 70-80% functionalization at the target  ...[more]

Similar Datasets

| S-EPMC6920564 | biostudies-literature
| S-EPMC2253670 | biostudies-literature
| S-EPMC8604393 | biostudies-literature
| S-EPMC3649871 | biostudies-literature
| S-EPMC6143613 | biostudies-literature
| S-EPMC3843242 | biostudies-literature
| S-EPMC6992699 | biostudies-literature
| S-EPMC5133248 | biostudies-literature
| S-EPMC4727922 | biostudies-literature
| S-EPMC6628638 | biostudies-literature